2-(Trifluoromethoxy)Benzaldehyde for Kinase Inhibitor Synthesis
Comparative Technical Specifications of CAS 94651-33-9 and CAS 447-61-0 for Kinase Inhibitor Synthesis
In the development of tricyclic compounds for use as kinase inhibitors, the selection of the aryl aldehyde derivative is critical for final binding affinity. CAS 94651-33-9, known as 2-(Trifluoromethoxy)benzaldehyde, offers distinct electronic properties compared to the structurally similar CAS 447-61-0 (2-Trifluoromethylbenzaldehyde). While both contain fluorine motifs, the ether linkage in the trifluoromethoxy group alters the electron density on the aromatic ring, influencing the nucleophilic attack during condensation reactions common in indanone synthesis. Recent literature regarding tricyclic kinase inhibitors highlights the importance of this substitution pattern for optimizing potency against targets such as EGFR and VEGFR2.
From a process engineering perspective, the physical behavior of these intermediates differs significantly during handling. A non-standard parameter often overlooked in basic datasheets is the viscosity shift of the neat liquid at sub-zero temperatures. During winter shipping, CAS 94651-33-9 may exhibit increased viscosity or partial crystallization if not properly stabilized, which can complicate automated dosing systems in large-scale reactors. Unlike the direct carbon-fluorine bond in CAS 447-61-0, the oxygen bridge in 2-Trifluoromethoxybenzaldehyde introduces a dipole moment that affects solubility in polar aprotic solvents used during the final coupling stages.
Defining Purity Grades and Impurity Profiles for 2-(Trifluoromethoxy)benzaldehyde Reactivity
For medicinal chemistry intermediates, industrial purity is not merely a percentage but a definition of specific contaminant thresholds. The primary impurity concern for CF3O-Benzaldehyde is the presence of unreacted 2-(trifluoromethoxy)phenol from the upstream synthesis route. Even trace amounts of phenolic impurities can act as radical scavengers or unintended nucleophiles, potentially inhibiting the desired condensation reaction or altering the color profile of the final API. Additionally, oxidation to the corresponding benzoic acid must be monitored, as acidic conditions can catalyze premature self-condensation of the aldehyde.
When evaluating suppliers, request detailed gas chromatography (GC) traces that specifically quantify isomeric impurities. The ortho-substitution pattern is vital for the steric constraints required in kinase hinge binding. Meta or para isomers, if present above 0.1%, can lead to difficult-to-remove byproducts during purification. At NINGBO INNO PHARMCHEM CO.,LTD., we emphasize the control of these specific isomeric profiles to ensure consistency across batches for long-term development projects.
Essential COA Parameters and Quality Control Metrics for Medicinal Chemistry Intermediates
Quality assurance in fluorinated benzaldehyde production relies on rigorous testing beyond standard assay values. A comprehensive Certificate of Analysis (COA) must include water content analysis, as moisture can lead to hemiacetal formation during storage. Furthermore, thermal stability data is essential for processes involving elevated temperatures. The following table outlines the critical technical parameters typically assessed for this intermediate compared to standard commercial grades.
| Parameter | Standard Commercial Grade | High-Purity Medicinal Grade | Test Method |
|---|---|---|---|
| Assay (GC Area %) | > 98.0% | > 99.5% | GC-FID |
| Water Content | < 0.5% | < 0.1% | Karl Fischer |
| Isomeric Purity | Not Specified | > 99.0% (Ortho) | GC-MS |
| Acid Value | < 1.0 mg KOH/g | < 0.5 mg KOH/g | Titration |
| Appearance | Colorless to Pale Yellow | Water White | Visual/Ph.Eur |
| Batch Consistency | Variable | Validated | Refer to the batch-specific COA |
It is imperative to note that specific numerical specifications for melting point or boiling point can vary based on atmospheric pressure and equipment calibration. Please refer to the batch-specific COA for exact numerical values relevant to your current procurement cycle.
Bulk Packaging Solutions and Storage Stability for Trifluoromethoxy Benzaldehyde Derivatives
Physical integrity during transit is as crucial as chemical purity. For bulk quantities, we utilize nitrogen-padded 210L drums or IBC tanks to prevent moisture ingress and oxidation. The trifluoromethoxy group is generally stable, but prolonged exposure to ambient light and humidity can degrade quality over time. Storage recommendations include keeping containers tightly closed in a cool, dry, and well-ventilated area away from incompatible materials such as strong oxidizing agents.
Logistics planning should account for temperature sensitivity. While we do not make regulatory environmental claims, our physical packaging is designed to maintain product integrity during standard shipping conditions. For regions experiencing extreme temperature fluctuations, additional insulation or temperature-controlled containers are advised to prevent the viscosity shifts mentioned earlier. Proper handling ensures that the synthesis route downstream remains unaffected by packaging-induced degradation.
Scaling Medicinal Chemistry Pathways Using Validated CAS 94651-33-9 Data Sheets
Transitioning from milligram-scale discovery to kilogram-scale production requires validated data sheets that reflect real-world processing conditions. Recent studies on 2-benzylidene-1-indanone compounds demonstrate the utility of substituted benzaldehydes in generating antitumor activities. Scaling these pathways requires confidence in the raw material's consistency. Variations in aldehyde purity can disproportionately affect yield and purification costs at scale.
Our engineering team supports custom synthesis requirements to align with specific process chemistries. Whether adapting a pathway described in patent literature like WO2013004984A1 for tricyclic kinase inhibitors or developing novel indanone derivatives, having a stable supply of validated intermediates is key. We provide technical support to help troubleshoot scale-up issues related to reagent quality, ensuring that the transition from lab to pilot plant proceeds without chemical bottlenecks.
Frequently Asked Questions
What is the typical lead time for bulk orders of CAS 94651-33-9?
Lead times vary based on current inventory levels and production scheduling. Please contact our sales team for a specific timeline regarding your required tonnage.
Can you provide a sample for preliminary R&D testing?
Yes, we support R&D efforts with sample quantities. Technical specifications for samples match our production standards, subject to availability.
What documentation is provided with the shipment?
Each shipment includes a comprehensive COA, safety data sheet (SDS), and packing list. Specific regulatory documents depend on the destination country's requirements.
Is the packaging suitable for long-term storage?
Our nitrogen-padded drums are designed for stability. However, we recommend adhering to the storage conditions listed on the label to ensure maximum shelf life.
Sourcing and Technical Support
Securing a reliable supply chain for specialized fluorinated intermediates is essential for uninterrupted drug development. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality chemical solutions with transparent technical data. We focus on delivering physical product quality and logistical reliability to support your manufacturing goals. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.